Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Boston ScientificBecton, Dickinson andBaxter InternationalDexComResMed
SymbolNYSE:BSXNYSE:BDXNYSE:BAXNASDAQ:DXCMNYSE:RMD
Price Information
Current Price$40.86$257.85$85.80$399.49$204.20
52 Week RangeBuyBuyBuyBuyBuy
MarketRank™
Overall Score2.02.01.91.91.5
Analysis Score2.41.31.33.41.3
Community Score2.72.32.73.01.8
Dividend Score0.03.32.50.01.7
Ownership Score1.71.71.71.71.7
Earnings & Valuation Score3.11.31.31.31.3
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$43.62$281.55$92.38$442.75$196.00
% Upside from Price Target6.75% upside9.19% upside7.67% upside10.83% upside-4.02% downside
Trade Information
Market Cap$58.04 billion$74.92 billion$43.34 billion$38.63 billion$29.71 billion
Beta0.870.790.650.860.28
Average Volume9,293,7141,314,8572,723,689834,573665,614
Sales & Book Value
Annual Revenue$10.74 billion$17.12 billion$11.36 billion$1.48 billion$2.96 billion
Price / Sales5.414.383.8126.1710.05
Cashflow$2.70 per share$17.40 per share$5.33 per share$2.63 per share$5.70 per share
Price / Cash15.1214.8216.11151.6635.83
Book Value$9.96 per share$81.98 per share$15.50 per share$9.64 per share$17.26 per share
Price / Book4.103.155.5441.4411.83
Profitability
Net Income$4.70 billion$874 million$1.00 billion$101.10 million$621.67 million
EPS$1.58$10.20$3.31$1.84$4.76
Trailing P/E Ratio15.6694.4548.75165.0843.82
Forward P/E Ratio25.3819.2624.94120.6936.99
P/E Growth2.302.342.536.152.86
Net Margins36.59%5.11%7.90%12.69%22.45%
Return on Equity (ROE)11.77%13.30%20.81%27.29%30.64%
Return on Assets (ROA)5.57%5.60%8.78%10.45%16.43%
Dividend
Annual PayoutN/A$3.32$0.98N/A$1.56
Dividend YieldN/A1.29%1.14%N/A0.76%
Three-Year Dividend GrowthN/A8.84%56.56%N/A14.71%
Payout RatioN/A32.55%29.61%N/A32.77%
Years of Consecutive Dividend GrowthN/A50 Years5 YearsN/A1 Years
Debt
Debt-to-Equity Ratio0.60%0.72%0.67%1.10%0.39%
Current Ratio1.87%1.54%2.64%6.39%2.61%
Quick Ratio1.42%1.07%2.06%6.00%1.80%
Ownership Information
Institutional Ownership Percentage90.70%83.22%82.89%94.06%68.64%
Insider Ownership Percentage0.70%0.76%0.13%0.69%1.33%
Miscellaneous
Employees36,00070,00050,0005,5007,770
Shares Outstanding1.42 billion290.56 million505.10 million96.71 million145.51 million
Next Earnings Date4/28/2021 (Confirmed)5/6/2021 (Confirmed)4/29/2021 (Confirmed)4/29/2021 (Confirmed)4/29/2021 (Confirmed)
OptionableOptionableOptionableOptionableOptionableOptionable
SourceHeadline
CPAP Masks Market to See Huge Growth by 2026 | ResMed, BMC Medical, Hans Rudolph – Los Hijos de la Malinche - Los Hijos de la MalincheCPAP Masks Market to See Huge Growth by 2026 | ResMed, BMC Medical, Hans Rudolph – Los Hijos de la Malinche - Los Hijos de la Malinche
loshijosdelamalinche.com - April 15 at 6:01 PM
June 18th Options Now Available For ResMed (RMD) - NasdaqJune 18th Options Now Available For ResMed (RMD) - Nasdaq
nasdaq.com - April 15 at 6:01 PM
ResMed Stock Is Estimated To Be Significantly Overvalued - Yahoo FinanceResMed Stock Is Estimated To Be Significantly Overvalued - Yahoo Finance
finance.yahoo.com - April 15 at 1:50 AM
2 Companies Whose Products, and Profits, Could Help You Sleep Better at Night - The Motley Fool2 Companies Whose Products, and Profits, Could Help You Sleep Better at Night - The Motley Fool
fool.com - April 14 at 3:49 PM
How Will the Market React to ResMed Inc. (RMD) Stock Getting a Bullish Rating - InvestorsObserverHow Will the Market React to ResMed Inc. (RMD) Stock Getting a Bullish Rating - InvestorsObserver
investorsobserver.com - April 14 at 3:49 PM
ResMed Inc. (NYSE:RMD) CFO Sells $496,175.00 in StockResMed Inc. (NYSE:RMD) CFO Sells $496,175.00 in Stock
americanbankingnews.com - April 13 at 8:44 PM
Insider Selling: ResMed Inc. (NYSE:RMD) Insider Sells 4,800 Shares of StockInsider Selling: ResMed Inc. (NYSE:RMD) Insider Sells 4,800 Shares of Stock
americanbankingnews.com - April 13 at 8:12 PM
Global Polysomnography Systems Market Latest Analysis 2020 – Philips, Cleveland, Garmin, ResMed, Natus Medical, Fitbit – ROUGH Magazine - ROUGH MagazineGlobal Polysomnography Systems Market Latest Analysis 2020 – Philips, Cleveland, Garmin, ResMed, Natus Medical, Fitbit – ROUGH Magazine - ROUGH Magazine
rough.asia - April 12 at 6:37 PM
Sleep Apnea Monitoring Instruments Market has Huge Demand in Worldwide| ResMed, Philips Healthcare, Fisher & Paykel Healthcare, SomnoMed, Compumedics – FLA News - FLA NewsSleep Apnea Monitoring Instruments Market has Huge Demand in Worldwide| ResMed, Philips Healthcare, Fisher & Paykel Healthcare, SomnoMed, Compumedics – FLA News - FLA News
flanewsonline.com - April 12 at 8:35 AM
ResMed Inc. - Consensus Indicates Potential 10.1% Upside - DirectorsTalk InterviewsResMed Inc. - Consensus Indicates Potential 10.1% Upside - DirectorsTalk Interviews
directorstalkinterviews.com - April 10 at 7:56 AM
Intensive Care Unit Equipment (COVID-19) Market 2020 Global Industry Outlook – Resmed, Sorin Group, Philips Healthcare, BD – ROUGH Magazine - ROUGH MagazineIntensive Care Unit Equipment (COVID-19) Market 2020 Global Industry Outlook – Resmed, Sorin Group, Philips Healthcare, BD – ROUGH Magazine - ROUGH Magazine
rough.asia - April 9 at 2:17 PM
ResMed to Report Third Quarter Fiscal 2021 Earnings on April 29, 2021 - Yahoo FinanceResMed to Report Third Quarter Fiscal 2021 Earnings on April 29, 2021 - Yahoo Finance
finance.yahoo.com - April 8 at 6:40 PM
ResMed Inc. stock rises Wednesday, outperforms market - MarketWatchResMed Inc. stock rises Wednesday, outperforms market - MarketWatch
marketwatch.com - April 7 at 7:01 PM
ResMed, Verily venture renamed Primasun - HME NewsResMed, Verily venture renamed Primasun - HME News
hmenews.com - April 7 at 1:58 PM
ResMed Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatchResMed Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
marketwatch.com - April 6 at 6:47 PM
ResMed expands AirView Remote Ventilation platform in India - BSI bureauResMed expands AirView Remote Ventilation platform in India - BSI bureau
biospectrumindia.com - April 6 at 1:46 PM
ResMed expands AirView Remote Monitoring for ventilation in India - Express HealthcareResMed expands AirView Remote Monitoring for ventilation in India - Express Healthcare
expresshealthcare.in - April 6 at 8:46 AM
Acutus Medical (NASDAQ:AFIB) & ResMed (NYSE:RMD) Critical ComparisonAcutus Medical (NASDAQ:AFIB) & ResMed (NYSE:RMD) Critical Comparison
americanbankingnews.com - April 4 at 8:13 AM
Global Disposable Breathing and Anesthesia Supplies Market 2021 Key Players – ResMed, Philips Respironics, Ambu, Fisher & Paykel, BD, Teleflex, Smiths Medical – ROUGH Magazine - ROUGH MagazineGlobal Disposable Breathing and Anesthesia Supplies Market 2021 Key Players – ResMed, Philips Respironics, Ambu, Fisher & Paykel, BD, Teleflex, Smiths Medical – ROUGH Magazine - ROUGH Magazine
rough.asia - April 2 at 12:22 PM
Adult Ventilators Market Is Booming Worldwide | Philips Healthcare, ResMed – Investments Revolution - Investments RevolutionAdult Ventilators Market Is Booming Worldwide | Philips Healthcare, ResMed – Investments Revolution - Investments Revolution
investmentsrevolution.com - March 30 at 6:13 PM
ResMeds Hollingshead Speaks on Firms Growth - Medical Device and Diagnostics IndustryResMed's Hollingshead Speaks on Firm's Growth - Medical Device and Diagnostics Industry
mddionline.com - March 30 at 1:24 AM
Continuous Positive Airway Pressure Devices Market Analysis, Latest Trends, Growth 2021 | ResMed, Philips Healthcare, Fisher & Paykel, Medtronic - The Market EagleContinuous Positive Airway Pressure Devices Market Analysis, Latest Trends, Growth 2021 | ResMed, Philips Healthcare, Fisher & Paykel, Medtronic - The Market Eagle
themarketeagle.com - March 28 at 7:39 PM
Self-contained Breathing Apparatus (SCBA) Market Boosting the Growth Worldwide: ResMed, DeVilbiss Healthcare(Drive Medical), Fisher and Paykel Healthcare, Philips Respironics - The Market EagleSelf-contained Breathing Apparatus (SCBA) Market Boosting the Growth Worldwide: ResMed, DeVilbiss Healthcare(Drive Medical), Fisher and Paykel Healthcare, Philips Respironics - The Market Eagle
themarketeagle.com - March 27 at 3:35 AM
ResMed India conducted educational training: Intricacies in Application of Non- Invasive Ventilation (NIV) - NewsPatrollingResMed India conducted educational training: Intricacies in Application of Non- Invasive Ventilation (NIV) - NewsPatrolling
newspatrolling.com - March 26 at 7:33 AM
Noninvasive Positive-pressure Ventilation Market 2021 Comprehensive Insights – ResMed, Philips Healthcare, Vyaire Medical, Medtronic, GE Healthcare, eVent Medical - Investments RevolutionNoninvasive Positive-pressure Ventilation Market 2021 Comprehensive Insights – ResMed, Philips Healthcare, Vyaire Medical, Medtronic, GE Healthcare, eVent Medical - Investments Revolution
investmentsrevolution.com - March 25 at 3:55 PM
Needham & Company LLC Upgrades ResMed (NYSE:RMD) to "Buy"Needham & Company LLC Upgrades ResMed (NYSE:RMD) to "Buy"
marketbeat.com - March 16 at 7:13 AM
DateCompanyBrokerageAction
4/15/2021Boston ScientificAtlantic SecuritiesInitiated Coverage
2/12/2021Boston ScientificNeedham & Company LLCBoost Price Target
2/4/2021Boston ScientificRaymond JamesBoost Price Target
2/3/2021Boston ScientificPiper SandlerBoost Price Target
2/1/2021Boston ScientificDeutsche Bank AktiengesellschaftInitiated Coverage
12/15/2020Boston ScientificMorgan StanleyBoost Price Target
12/15/2020Boston ScientificThe Goldman Sachs GroupDowngrade
12/8/2020Boston ScientificBTIG ResearchReiterated Rating
11/18/2020Boston ScientificTruistLower Price Target
11/18/2020Boston ScientificCitigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellLower Price Target
11/18/2020Boston ScientificSmith Barney CitigroupLower Price Target
11/18/2020Boston ScientificWells Fargo & CompanyLower Price Target
9/11/2020Boston ScientificWolfe ResearchInitiated Coverage
7/30/2020Boston ScientificStifel NicolausBoost Price Target
7/30/2020Boston ScientificJefferies Financial GroupBoost Price Target
7/30/2020Boston ScientificSVB LeerinkBoost Price Target
7/29/2020Boston ScientificOppenheimerBoost Price Target
8/10/2020Becton, Dickinson andUBS GroupBoost Price Target
7/9/2020Becton, Dickinson andBarclaysUpgrade
7/2/2020Becton, Dickinson andWilliam BlairReiterated Rating
5/12/2020Becton, Dickinson andKeyCorpReiterated Rating
5/8/2020Becton, Dickinson andCfraLower Price Target
2/5/2021Baxter InternationalCredit Suisse GroupLower Price Target
9/4/2020Baxter InternationalArgusDowngrade
12/10/2020DexComCanaccord GenuityLower Price Target
10/30/2020ResMedJPMorgan Chase & Co.Upgrade
10/27/2020ResMedBank of AmericaUpgrade
2/3/2020ResMedCLSAInitiated Coverage
(Data available from 4/15/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.